Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Crowdsourcing Raises Billions for Families Hit Hard by Medical BillsBiden Says He Will Release All Vaccine Doses After Taking Office1 in 4 Doctors Harassed Online, Study FindsMoves, Evictions Often Trigger Harmful Breaks in Health Care: StudySome Americans Can't Access Telemedicine, Study ShowsHealth Care After COVID: The Rise of TelemedicineNeurologists Much Tougher to Find in Rural AmericaAs Testing Costs Rise, Neurology Patients May Skip Screening1 in 7 Studies in Nutrition Journals Have Food Industry TiesUSPS Cuts Could Pose Harm If Mail-Order Meds Delayed: Study329 Americans Are Injured by Guns Every Day: StudySome Talc Products Contain Asbestos: StudyAHA News: Why People Fear Performing CPR on Women – and What to Do About It'Green Prescriptions' May Backfire for SomePreventive Health Care Falls by Wayside During PandemicSmoking Bans Don't Work If Not Enforced, NYC Study FindsTelemedicine Out of Reach for Those Who Can't Get OnlineLies Spread on Social Media May Mean Fewer Vaccinations1 in 3 Americans Prescribed Inappropriate DrugsColon Cancer Screening Should Start at Age 45: Task ForceWhat Will It Take for People to Embrace a COVID Vaccine?What Will Convince Americans to Get a COVID-19 Vaccine?CDC Recommends Face Masks in All Public Transportation SettingsInsured Patients Are Getting Surprise Bills After ColonoscopiesBogus 'Cure' Claims Have U.S. Consumers Snapping Up CBD ProductsPediatricians' Group Tackles Racism in Health CareAs Virtual Doctor Visits Spike, Concerns About Equity, Missed Diagnoses GrowWas FDA Lax in Approving Opioids Too Easily?Allowing More Gay Men to Donate Corneas Could Save Sight for Thousands: StudyAccuracy of COVID-19 Antibody Tests Varies Widely, Study FindsCould Drones Delivering Defibrillators Save Lives?Statins Going Generic Saved Medicare BillionsAHA News: Looming Wave of Evictions, Housing Instability Pose Threat to HealthAHA News: Health Apps Pose Privacy Risks, But Experts Offer This AdviceCould You Save a Life After Mass Violence? Most Americans Say NoGun Violence Costs U.S. Health Care System $170 Billion AnnuallyWith COVID Vaccine in Works, 1 in 5 Americans Doesn't Believe in ShotsTelehealth Skyrocketing Among Older AdultsPharmacists in All U.S. States Can Give Kids Childhood ShotsAHA News: COVID-19's Economic Fallout Expands Food Insecurity, as Groups Scramble to HelpCOVID-19 Clinical Trials Lack Diversity, Researchers SayLook Beyond Fossil Fuels to Curb Air PollutionTelemedicine Is Here: Experts Offer Tips for SeniorsMany Older Adults Can't Connect With Telehealth: StudyAHA News: High-Speed Internet Offers Key Connection to Health, But Millions Lack It11 States Could Face ICU Doc Shortages as Coronavirus Cases SurgeWill the Telemedicine Boom Outlast the Pandemic?Yet Another Study Finds Vaccines Are SafeIn Rush to Publish, Most COVID-19 Research Isn't Reliable, Experts SayWith Tighter Handgun Laws, U.S. Would See Fewer Suicides by Young People
Links
Related Topics

Health Insurance
Healthcare

Yet Another Study Finds Vaccines Are Safe

HealthDay News
by By Dennis Thompson
HealthDay Reporter
Updated: Jul 28th 2020

new article illustration

TUESDAY, July 28, 2020 (HealthDay News) -- Vaccines remain a "remarkably safe" way to protect human health, thanks to a rigorous system of safety monitoring that continues after approval, a new review shows.

Ongoing safety monitoring led to safety-related label changes in 25 out of 57 vaccines approved by the U.S. Food and Drug Administration over a two-decade period, mostly related to the vaccine's effect on specific groups of vulnerable people, an Israeli research team found.

"This report is the most comprehensive study of post-marketing vaccine safety published, and it shows that vaccines are remarkably safe, and that the current vaccine approval and post-marketing surveillance processes are robust and effective," said senior researcher Dr. Daniel Shepshelovich, of Tel Aviv University's Sackler School of Medicine.

Vaccine hesitancy among Americans has been highlighted as a potential problem in the nation's response to the COVID-19 pandemic, with some experts concerned that too many folks simply won't get a coronavirus vaccine even if one proves safe and effective.

"The current COVID-19 outbreak makes us further appreciate the importance of safe and effective vaccines against infectious diseases," said Dr. Daniel Mackey, a pediatrician with CHOC Children's in Orange, Calif.

"As the world races to create a vaccine against COVID-19, we will now more than any other time in recent history be dependent on a robust vaccine adverse event reporting system to ensure that the chosen vaccines are safe for the greater population," he said.

For the study, Shepshelovich and his colleagues tracked the progress of 57 vaccines that were FDA-approved between January 1996 and December 2015.

Researchers found that 25 of the vaccines had a total 58 safety-related label changes that occurred following the approval.

More than a third of the label changes involved specific groups of people that were found to be potentially at a higher risk of health problems related to specific vaccines -- for example, immune-compromised patients, pregnant women or preterm infants, Shepshelovich said.

Another 22% of label changes involved allergic reactions to vaccines, researchers reported. Most of these allergies related to latex used in the packaging.

Only one vaccine was withdrawn from the market, a rotavirus vaccine that increased the risk of an intestinal obstruction, researchers found.

"A timely alarm was sounded, and the vaccine was quickly removed from use," Mackey said.

Overall, the safety monitoring data "represents an excellent track record, probably reflecting the professionalism and diligence of the personnel involved in the development, approval and regulation of vaccines," Shepshelovich concluded.

Flu vaccines were found to have the fewest post-approval safety issues, with only 3 of 21 influenza vaccines requiring a label change, compared with 22 of 36 other vaccines.

"It's important for people who have vaccine hesitancy to see that there are robust studies out there that support the use of vaccines," said Dr. Amesh Adalja, a senior scholar with the Johns Hopkins Center for Health Security in Baltimore.

"These are rigorously tested, and even after something is approved we're continuing to track the safety of that vaccine," he noted. "It really should give people who worry about vaccine safety a lot of confidence about how robust the process is for assessing the safety of these vaccines."

The new study was published July 27 in the Annals of Internal Medicine.

More information

The U.S. Centers for Disease Control and Prevention has more about vaccine safety.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net